Animal Models of Human Granulocyte Diseases

Hematology/Oncology Clinics of North America

Volumn 27, Issue 1, 2013, Pages 129-148

  Schäffer, Alejandro A ^a   Klein, Christoph ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Chronic granulomatous disease; Leukocyte adhesion deficiency; Mouse models; Neutrophils; Severe congenital neutropenia; Zebrafish models

Indexed keywords

ANIMAL MODEL; CHRONIC GRANULOMATOUS DISEASE; CONGENITAL DISORDER OF GLYCOSYLATION TYPE 2C; COW; DISEASE CLASSIFICATION; EXPERIMENTAL DOG; GENE MUTATION; GRANULOCYTE DISEASE; HUMAN; LEUKOCYTE ADHESION DEFICIENCY; LEUKOCYTE ADHESION DEFICIENCY TYPE I; LEUKOCYTE ADHESION DEFICIENCY TYPE III; LEUKOCYTE DISORDER; MUTAGENESIS; NONHUMAN; PAPILLON LEFEVRE SYNDROME; PRIORITY JOURNAL; RAC2 DISEASE; REVIEW; SEVERE CONGENITAL NEUTROPENIA; TREND STUDY; ZEBRA FISH;

ANIMALS; CATTLE; DISEASE MODELS, ANIMAL; DOGS; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; LEUKOCYTE DISORDERS; LEUKOCYTE-ADHESION DEFICIENCY SYNDROME; MICE; NEUTROPENIA; ZEBRAFISH;

EID: 84872734004     PISSN: 08898588     EISSN: 15581977     Source Type: Journal    
DOI: 10.1016/j.hoc.2012.10.005     Document Type: Review

References (103)

1. Kita H. Eosinophils: multifaceted biological properties and roles in health and disease. Immunol Rev 2011, 242:161-177.
2. Karasuyama H., Mukai K., Obata K., et al. Nonredundant roles of basophils in immunity. Annu Rev Immunol 2011, 29:45-69.
3. Lepelley P., Zandecky M., Parquet S., et al. Total peroxidase deficiency in eosinophils: a report on twin sisters, one with a refractory anaemia. Eur J Haematol 1987, 39:77-81.
4. Ohnmacht C., Schwartz C., Panzer M., et al. Basophils orchestrate chronic allergic dermatitis and protective immunity against helminths. Immunity 2010, 33:364-374.
5. Dale D.C., Boxer L., Liles W.C. The phagocytes: neutrophils and monocytes. Blood 2008, 112:935-945.
6. Segal A.W. How neutrophils kill microbes. Annu Rev Immunol 2005, 23:197-223.
7. Fuchs T.A., Abed U., Goosmann C., et al. Novel cell death program leads to neutrophil extracellular traps. J Cell Biol 2007, 176:231-241.
8. Styrt B. Species variation in neutrophil biochemistry and function. J Leukoc Biol 1989, 46:63-74.
9. Lieschke G.J., Trede N.S. Fish immunology. Curr Biol 2009, 19:R678-R682.
10. Qiu P., Pan P.C., Govind S. A role for the Drosophila Toll/Cactus pathway in larval hematopoiesis. Development 1998, 125:1909-1920.
11. phox and selective deficits in neutrophil NADPH oxidase activity. Blood 2009, 114:3309-3315.
12. Sancho-Shimizu V., Malo D. Sequencing, expression, and functional analyses support the candidacy of Ncf2 in susceptibility to Salmonella typhimurium infection in wild-derived mice. J Immunol 2006, 176:6954-6961.
13. Nakano Y., Longo-Guess C.M., Bergstrom D.E., et al. Mutation of the Cyba gene encoding p22phox causes vestibular and immune defects in mice. J Clin Invest 2008, 118:1176-1185.
14. Pollock J.D., Williams D.A., Gifford M.A., et al. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat Genet 1995, 9:202-208.
15. Jackson S.H., Gallin J.I., Holland S.M. The p47phox mouse knock-out model of chronic granulomatous disease. J Exp Med 1995, 182:751-758.
16. Ellson C.D., Davidson K., Ferguson G.J., et al. Neutrophils from p40phox-/- mice exhibit severe defects in NADPH oxidase regulation and oxidant-dependent bacterial killing. J Exp Med 2006, 203:1927-1937.
17. Deng Q., Yoo S.K., Cavnar P.J., et al. Dual roles for Rac2 in neutrophil motility and active retention in zebrafish hematopoietic tissue. Dev Cell 2011, 21:735-745.
18. Ambruso D.R., Knall C., Abell A.N., et al. Human neutrophil immunodeficiency syndrome is associated with an inhibitory Rac2 mutation. Proc Natl Acad Sci U S A 2000, 97:4654-4659.
19. Accetta D., Syverson G., Bonacci B., et al. Human phagocyte defect caused by a Rac2 mutation detected by means of neonatal screening for T-cell lymphopenia. J Allergy Clin Immunol 2011, 127:535-538.e2.
20. Springer T.A., Thompson W.S., Miller L.J., et al. Inherited deficiency of the Mac-1, LFA-1, p150,95 glycoprotein family and its molecular basis. J Exp Med 1984, 160:1901-1918.
21. Wilson R.W., Ballantyne C.M., Smith C.W., et al. Gene targeting yields a CD18-mutant mouse for study of inflammation. J Immunol 1993, 151:1571-1578.
22. Scharffetter-Kochanek K., Lu H., Norman K., et al. Spontaneous skin ulceration and defective T cell function in CD18 null mice. J Exp Med 1998, 188:119-131.
23. Nagahata H. Bovine leukocyte adhesion deficiency (BLAD): a review. J Vet Med Sci 2004, 66:1475-1482.
24. Lübke T., Marquardt T., Etzioni A., et al. Complementation cloning identifies CDG-IIc, a new type of congenital disorders of glycosylation, as a GDP-fucose transporter deficiency. Nat Genet 2001, 28:73-76.
25. Lühn K., Wild M.K., Eckhardt M., et al. The gene defective in leukocyte adhesion deficiency II encodes a putative GDP-fucose transporter. Nat Genet 2001, 28:69-72.
26. Hellbusch C.C., Sperandio M., Frommhold D., et al. Golgi GDP-fucose transporter-deficient mice mimic congenital disorder of glycosylation IIc/leukocyte adhesion deficiency II. J Biol Chem 2007, 282:10762-10772.
27. Kuijpers T.W., van de Vijver E., Weterman M.A., et al. LAD-1/variant syndrome is caused by mutations in FERMT3. Blood 2009, 113:4740-4746.
28. Malinin N.L., Zhang L., Choi J., et al. A point mutation in KINDLIN3 ablates activation of three integrin subfamilies in humans. Nat Med 2009, 15:313-318.
29. Svensson L., Howarth K., McDowall A., et al. Leukocyte adhesion deficiency-III is caused by mutations in KINDLIN3 affecting integrin activation. Nat Med 2009, 15:306-312.
30. Moser M., Nieswandt B., Ussar S., et al. Kindlin-3 is essential for integrin activation and platelet aggregation. Nat Med 2008, 14:325-330.
31. Moser M., Bauer M., Schmid S., et al. Kindlin-3 is required for β-2 integrin-mediated leukocyte adhesion to endothelial cells. Nat Med 2009, 15:300-305.
32. Williams D.A., Tao W., Yang F., et al. Dominant negative mutation of the hematopoietic-specific Rho GTPase, Rac2, is associated with a human phagocyte immunodeficiency. Blood 2000, 96:1646-1654.
33. Gu Y., Filippi M.D., Cancelas J.A., et al. Hematopoietic cell regulation by Rac1 and Rac2 guanosine triphosphatases. Science 2003, 302:445-449.
34. Roberts A.W., Kim C., Zhen L., et al. Deficiency of the hematopoietic cell-specific Rho family GTPase Rac2 is characterized by abnormalities in neutrophil function and host defense. Immunity 1999, 10:183-196.
35. Walters K.B., Green J.M., Surfus J.C., et al. Live imaging of neutrophil motility in a zebrafish model of WHIM syndrome. Blood 2010, 116:2803-2811.
36. Haddy T.B., Rana S.R., Castro O. Benign ethnic neutropenia: what is a normal absolute neutrophil count?. J Lab Clin Med 1999, 133:15-22.
37. Dale D.C., Bonilla M.A., Davis M.W., et al. A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood 1993, 81:2496-2502.
38. Liu F., Wu H.Y., Wesselschmidt R., et al. Impaired production and increased apoptosis of neutrophils in granulocyte colony-stimulating factor receptor-deficient mice. Immunity 1995, 5:491-501.
39. Plo I., Zhang Y., Le Couédic J.P., et al. An activating mutation in the CSF3R gene induces a hereditary chronic neutrophilia. J Exp Med 2009, 206:1701-1707.
40. Jung J., Bohn G., Allroth A., et al. Identification of a homozygous deletion in the AP3B1 gene causing Hermansky-Pudlak syndrome, type 2. Blood 2006, 108:362-369.
41. Elsner J., Roesler J., Emmendörffer A., et al. Abnormal regulation in the signal transduction in neutrophils from patients with severe congenital neutropenia: relation of impairs mobilization of cytosolic free calcium to altered chemotaxis, superoxide anion generation and F-actin content. Exp Hematol 1993, 21:38-46.
42. Schäffer A.A., Klein C. Genetic heterogeneity in severe congenital neutropenia: how many aberrant pathways can kill a neutrophil?. Curr Opin Allergy Clin Immunol 2007, 7:481-494.
43. Okada Y., Kamatani Y., Takahashi A., et al. Common variations in PSMD3-CSF3 and PLCB4 are associated with neutrophil count. Hum Mol Genet 2010, 19:2079-2085.
44. Schmid J.P., Ho C.H., Diana J., et al. A Griscelli syndrome type 2 murine model of hemophagocytic lymphohistiocytosis (HLH). Eur J Immunol 2008, 38:3219-3225.
45. Klein C., Grudzien M., Appaswamy G., et al. Deficiency of HAX1 causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nat Genet 2007, 39:86-92.
46. Boztug K., Appaswamy G., Ashikov A., et al. A syndrome with congenital neutropenia and mutations in G6PC3. N Engl J Med 2009, 360:32-43.
47. Cheung Y.Y., Kim S.Y., Yiu W.H., et al. Impaired neutrophil activity and increased susceptibility to bacterial infection in mice lacking glucose-6-phosphatase-ß. J Clin Invest 2007, 117:784-793.
48. Chao J.R., Parganas E., Boyd K., et al. Hax1-mediated processing of HtrA2 by Parl allows survival of lymphocytes and neurons. Nature 2008, 452:98-102.
49. Kostmann R. Infantile genetic agranulocytosis (Agranulocystosis infantilis hereditaria): a new recessive lethal disease in man. Acta Paediatr 1956, 45(Suppl):1-78.
50. Germeshausen M., Grudzien M., Zeidler C., et al. Novel HAX1 mutations in patients with severe congenital neutropenia reveal isoform-dependent genotype-phenotype associations. Blood 2008, 111:4954-4957.
51. Shearman J.R., Wilton A.N. A canine model of Cohen syndrome: trapped neutrophil syndrome. BMC Genomics 2011, 12:258.
52. Kolehmainen J., Black G.C., Saarinen A., et al. Cohen syndrome is caused by mutations in a novel gene, COH1, encoding a transmembrane protein with a presumed role in vesicle-mediated sorting and intracellular protein transport. Am J Hum Genet 2003, 72:1359-1369.
53. Cohen M.M., Hall B.D., Smith D.W., et al. A new syndrome with hypotonia, obesity, mental deficiency, and facial, oral, ocular and limb anomalies. J Pediatr 1973, 83:280-284.
54. Norio R., Raitta C., Lindahl E. Further delineation of the Cohen syndrome; report on chorioretinal dystrophy, leukopenia and consanguinity. Clin Genet 1984, 25:1-14.
55. Zarebski A., Velu C.S., Baktula A.M., et al. Mutations in growth factor independent-1 associated with human neutropenia block murine granulopoiesis through colony stimulating factor-1. Immunity 2008, 28:370-380.
56. Person R.E., Li F.Q., Duan Z., et al. Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2. Nat Genet 2003, 34:308-312.
57. Hernandez P.A., Gorlin R.J., Lukens J.N., et al. Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease. Nat Genet 2003, 34:70-74.
58. Ridanpää M., van Eenennaam H., Pelin K., et al. Mutations in the RNA component of RNase MRP cause a pleiotropic human disease, cartilage-hair hypoplasia. Cell 2001, 104:195-203.
59. Volpi L., Roversi G., Colombo E.A., et al. Targeted next-generation sequencing appoints C16orf57 as Clericuzio-type poikiloderma with neutropenia gene. Am J Hum Genet 2010, 86:72-76.
60. Hamasaki A., Sendo F., Nakayama K., et al. Accelerated neutrophil apoptosis in mice lacking A1-a, a subtype of the bcl-2-related A1 gene. J Exp Med 1998, 188:1985-1992.
61. Dzhagalov I., St John A., He Y.W. The antiapoptotic protein Mcl-1 is essential for the survival of neutrophils but not macrophages. Blood 2007, 109:1620-1626.
62. Lagresle-Peyrou C., Six E.M., Picard C., et al. Human adenylate kinase 2 deficiency causes a profound hematopoietic defect associated with sensorineural deafness. Nat Genet 2009, 41:106-111.
63. Pannicke U., Honig M., Hess I., et al. Reticular dysgenesis (aleukocytosis) is caused by mutations in the gene encoding mitochondrial adenylate kinase 2. Nat Genet 2009, 41:101-105.
64. Hart T.C., Hart P.S., Bowden D.W., et al. Mutations of the cathepsin C gene are responsible for Papillon-Lefèvre syndrome. J Med Genet 1999, 36:881-887.
65. Toomes C., James J., Wood A.J., et al. Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis. Nat Genet 1999, 23:421-424.
66. Pham C.T., Ley T.J. Dipeptidyl peptidase I is required for the processing and activation of granzymes A and B in vivo. Proc Natl Acad Sci U S A 1999, 96:8627-8632.
67. Pagano M.B., Bartoli M.A., Ennis T.L., et al. Critical role of dipeptidyl peptidase I in neutrophil recruitment during the development of experimental abdominal aortic aneurysms. Proc Natl Acad Sci U S A 2007, 104:2855-2860.
68. Huang C.K., Zhan L., Hannigan M.O., et al. P47phox-deficient NADPH oxiase defect in neutrophils of diabetic mouse strains, C57BL/6J-m db/db and db/+. J Leukoc Biol 2000, 67:210-215.
69. Hultqvist M., Oloffson P., Holmberg J., et al. Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burts due to a mutation in the Ncf1 gene. Proc Natl Acad Sci U S A 2004, 101:12646-12651.
70. Vethanayagam R.R., Almyroudis N.G., Grimm M.J., et al. Role of NADPH oxidase versus neutrophil proteases in antimicrobial host defense. PLoS One 2011, 6:e28149.
71. Colucci-Guyon E., Tinevez J.Y., Renshaw S.A., et al. Strategies of professional phagocytes in vivo: unlike macrophages, neutrophils engulf only surface-assoicated microbes. J Cell Sci 2011, 124:3053-3059.
72. Khuchua Z., Ye Z., Batts L., et al. A zebrafish mdel of human Barth syndrome reveals the essential role of tafazzin in cardiac development and function. Circ Res 2006, 99:201-208.
73. Jacob C.O., Eisenstein M., Dinauer M.C., et al. Lupus-associated causal mutation in neutrophil cytosolic factor 2 (NCF2) brings unique insights to the structure and function of NADPH oxidase. Proc Natl Acad Sci U S A 2012, 109:E59-E67.
74. Muise A.M., Xu W., Guo C.H., et al. NADPH oxidase complex and IBD candidate gene studies: identification of a rare variant in NCF2 that results in reduced binding to RAC2. Gut 2012, 61:1028-1035.
75. Dinauer M.C., Pierce E.A., Bruns G.A., et al. Human neutrophil cytochrome b light chain (p22-phox): gene structure, chromosomal location, and mutations in cytochrome-negative autosomal recessive chronic granulomatous disease. J Clin Invest 1990, 86:1729-1737.
76. Nanua S., Murakami M., Xia J., et al. Activation of the unfolded protein response is associated with impaired granulopoiesis in transgenic mice expressing mutant Elane. Blood 2011, 117:3539-3547.
77. Beutler B., Moresco E.M. The forward genetic dissection of afferent innate immunity. Curr Top Microbiol Immunol 2008, 321:3-26.
78. Cook M.C., Vinuesa C.G., Goodnow C.C. ENU-mutagenesis: insight into immune function and pathology. Curr Opin Immunol 2006, 18:627-633.
79. Soewarto D., Fella C., Teubner A., et al. The large-scale Munich ENU-mouse-mutagenesis screen. Mamm Genome 2000, 11:507-510.
80. Runkel F., Büssow H., Seburn K.L., et al. Grey, a novel mutation in the murine Lyst gene, causes the beige phenotype by skipping of exon 25. Mamm Genome 2006, 17:203-210.
81. Blasius A.L., Arnold C.N., Georgel P., et al. Slc15a4, AP-3, and Hermansky-Pudlak syndrome proteins are required for Toll-like receptor signaling in plasmacytoid dendritic cells. Proc Natl Acad Sci U S A 2010, 107:19973-19978.
82. Xia J., Bolyard A.A., Rodger E., et al. Prevalence of mutations in ELANE, GFI1, HAX1, SBDS, WAS, and G6PC3 in patients with severe congenital neutropenia. Br J Haematol 2009, 147:535-542.
83. Smith B.N., Evans C., Ali A., et al. Phenotypic heterogeneity and evidence of a founder effect associated with G6PC3 mutations in patients with severe congenital neutropenia. Br J Haematol 2012, 10.1111/j.1365-2141.2012.09110.x.
84. Rosenberg P.S., Alter B.P., Bolyard A.A., et al. The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. Blood 2006, 107:4628-4635.
85. Mardiney M., Jackson S.H., Spratt S.K., et al. Enhanced host defense after gene transfer in the murine p47phox-deficient model of chronic granulomatous disease. Blood 1997, 89:2268-2275.
86. Jackson S.H., Miller G.F., Segal B.H., et al. IFN-gamma is effective in reducing infections in the mouse model of chronic granulomatous disease (CGD). J Interferon Cytokine Res 2001, 21:567-573.
87. Fernandez-Boyanapalli R., McPhillips K.A., Frasch S.C., et al. Impaired phagocytosis of apoptotic cells by macrophages in chronic granulomatous disease is reversed by IFN-γ in a nitric oxide-dependent manner. J Immunol 2010, 185:4030-4041.
88. Laine D.I., Busch-Petersen J. Inhibitors of cathepsin C (dipeptidyl peptidase I). Expert Opin Ther Pat 2010, 20:497-506.
89. Casimir C.M., Bu-Ghanim H.N., Rodaway A.R., et al. Autosomal recessive chronic granulomatous disease caused by deletion at a dinucleotide repeat. Proc Natl Acad Sci U S A 1991, 88:2753-2757.
90. Nunoi H., Iwata M., Tatsuzawa S., et al. AG dinucleotide insertion in a patient with chronic granulomatous disease lacking cytosolic 67-kD protein. Blood 1995, 86:329-333.
91. Dinauer M.C., Orkin S.H., Brown R., et al. The glycoprotein encoded by the X-linked chronic granulomatous disease locus is a component of the neutrophil cytochrome b complex. Nature 1987, 327:717-720.
92. Lieschke G.J., Grail D., Hodgson G., et al. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood 1994, 84:1737-1746.
93. Nagle D.L., Karim M.A., Woolf E.A., et al. Identification and mutation analysis of the complete gene for Chediak-Higashi syndrome. Nat Genet 1996, 14:307-311.
94. Belaaouaj A., McCarthy R., Baumann M., et al. Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis. Nat Med 1998, 4:615-618.
95. Grenda D.S., Johnson S.E., Mayer J.R., et al. Mice expressing a neutrophil elastase mutation derived from patients with severe congenital neutropenia have normal granulopoiesis. Blood 2002, 100:3221-3228.
96. Feng L., Seymour A.B., Jiang S., et al. The β3A subunit gene (Ap3b1) of the AP-3 adaptor complex is altered in the mouse hypopigmentation mutant pearl, a model for Hermansky-Pudlak syndrome and night blindness. Hum Mol Genet 1999, 8:323-330.
97. Wilson S.M., Yip R., Swing D.A., et al. A mutation in Rab27a causes the vesicle transport defects observed in ashen mice. Proc Natl Acad Sci U S A 2000, 97:7933-7938.
98. Karsunky H., Zen H., Schmidt T., et al. Inflammatory reactions and severe neutropenia in mice lacking the transcriptional repressor Gfi1. Nat Genet 2002, 30:295-300.
99. Hock H., Hamblen M.J., Rooke H.M., et al. Intrinsic requirement for zinc finger transcription factor Gfi-1 in neutrophil differentiation. Immunity 2003, 18:109-120.
100. Chen L.Y., Shieh J.J., Lin B., et al. Impaired glucose homeostasis, neutrophil trafficking and function in mice lacking the glucose-6-phosphate transporter. Hum Mol Genet 2003, 12:2547-2558.
101. Kim S.Y., Nguyen A.D., Gao J.L., et al. Bone marrow-derived cells require a functional glucose 6-phosphate transporter for normal myeloid functions. J Biol Chem 2006, 39:28794-28801.
102. Soustek M.S., Falk D.J., Mah C.S., et al. Characterization of a transgenic short hairpin RNA-induced murine model of tafazzin deficiency. Hum Gene Ther 2011, 22:865-871.
103. Benson K.F., Li F.Q., Person R.E., et al. Mutations associated with neutropenia in dogs and humans disrupt intracellular transport of neutrophil elastase. Nat Genet 2003, 35:90-96.